From Farm to Pharmacy: Strawberry-Enabled Oral Delivery of Protein Drugs
Authors:
- Nicholas G. LamsonNLNicholas G. Lamson
- Katherine C. FeinKFKatherine C. Fein
- John P. GleesonJGJohn P. Gleeson
- Sijie XianSXSijie Xian
- Alexandra NewbyANAlexandra Newby
- Namit ChaudharyNCNamit Chaudhary
- Jilian R. MelamedJMJilian R. Melamed
- Kyle CochranKCKyle Cochran
- Rebecca L. BallRBRebecca L. Ball
- Kanika SuriKSKanika Suri
- Vishal AhujaVAVishal Ahuja
- Anna ZhangAZAnna Zhang
Preprint
Abstract
Although oral drug delivery is preferred by patients, it is not possible for proteins because the gastrointestinal tract is not sufficiently permeable. To enable the non-toxic oral uptake of protein drugs, we investigated plant-based foods as intestinal permeation enhancers, hypothesizing that compounds found in food would be well-tolerated by the gastrointestinal tract. Following a screen of over 100 fruits, vegetables, herbs, and fungi, we identified strawberry as a potent enhancer of macromolecular permeability in vitro and in mice. Natural product chemistry techniques identified pelargonidin, an anthocyanidin, as the active compound. In mice, insulin was orally administered with pelargonidin to induce sustained pharmacodynamic effects with doses as low as 1 U/kg and bioactivity of over 100% relative to the current gold standard of subcutaneous injection. Pelargonidin-induced permeability was reversible within two hours of treatment, and one month of daily dosing did not adversely affect mice as determined by weight tracking, serum concentrations of inflammatory markers, and tight junction gene expression. Results underscore the utility of plant-based foods in biomedical applications and demonstrate pelargonidin as an especially potent enhancer for the oral delivery of biologics.Keywords
This publication has 29 references indexed in Scilit:
- Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniaePLOS ONE, 2017
- Structure-Function Analysis of Phenylpiperazine Derivatives as Intestinal Permeation EnhancersPharmaceutical Research, 2017
- Intestinal permeation enhancers for oral peptide deliveryAdvanced Drug Delivery Reviews, 2016
- Tight Junction Pore and Leak Pathways: A Dynamic DuoAnnual Review of Physiology, 2011
- Medication Adherence Leads To Lower Health Care Use And Costs Despite Increased Drug SpendingHealth Affairs, 2011
- Correlates of Insulin Injection OmissionDiabetes Care, 2010
- CLAUDINS AND EPITHELIAL PARACELLULAR TRANSPORTAnnual Review of Physiology, 2006
- Enhancing paracellular permeability by modulating epithelial tight junctionsPharmaceutical Science & Technology Today, 2000
- Injection related anxiety in insulin-treated diabetesDiabetes Research and Clinical Practice, 1999
- Design principles for orally bioavailable drugsDrug Discovery Today, 1996